E-Qure Overview

  • Status
  • Public
  • Employees
  • 1
Employees
  • Stock Symbol
  • EQUR
Stock Symbol
  • Share Price
  • $0.03
  • (As of Monday Closing)

E-Qure General Information

Description

E-Qure Corp is a medical device company. The company plans to commercialize its Bioelectrical Signal Therapy(BST) device. Its device treats wounds via electrical stimulation, which is believed to result in accelerated wound healing by imitating the natural electrical current that occurs in injured skin on the human body. BST Device is designed to treat chronic wounds - primarily Stage III and Stage IV ulcers.

Contact Information

Website
www.e-qure.com
Formerly Known As
ADB International Group Inc
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Stock Exchange
PINX
Primary Office
  • 20 West 64th Street
  • Suite 39G
  • New York, NY 10023
  • United States
+1 (728) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

E-Qure Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.06 $1.12M 34.5M 5.47K -$0.02

E-Qure Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 3,071 3,071 2,492 2,078
Revenue 0 0 0 0
EBITDA (596) (596) (430) (2,001)
Net Income (612) (612) (437) (2,014)
Total Assets 81 81 18 395
Total Debt 166 166 166 38
Public Fundamental Data provided by Morningstar, Inc. disclaimer

E-Qure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial